Dr. Campagnolo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 W Thomas Rd
Suite 300
Phoenix, AZ 85013Phone+1 602-406-6262Fax+1 602-406-6260
Education & Training
- Rutgers Health/New Jersey Medical SchoolResidency, Physical Medicine and Rehabilitation, 1989 - 1992
- OhioHealth/Riverside Methodist HospitalInternship, Transitional Year, 1988 - 1989
- Ohio State University College of MedicineClass of 1988
Certifications & Licensure
- AZ State Medical License 2004 - 2024
Publications & Presentations
PubMed
- Correction to: Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study.Jai Perumal, Roumen Balabanov, Ray Su, Roger Chang, Laura J. Balcer
Advances in Therapy. 2021-06-22 - 15 citationsNatalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label StudyJai Perumal, Roumen Balabanov, Ray Su, Roger Chang, Laura J. Balcer
Advances in Therapy. 2021-05-20 - 16 citationsStatistical analysis of PML incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the Stratify JCV® DxSelect™ antibody assay.Denise Campagnolo, Qunming Dong, Lily Lee, Pei-Ran Ho, Diogo Amarante
Journal of Neurovirology. 2016-10-11
Grant Support
- Health And Immunity Following Spinal Cord InjuryEunice Kennedy Shriver National Institute Of Child Health &Human Development2004–2008
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: